Scout Bio Closes $33 Million Series B2 Financing to Advance its Portfolio of Single Injection Gene Therapy Technology for the Treatment of Chronic Diseases in Pets

VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.